Log in to save to my catalogue

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6562046

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

About this item

Full title

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2019-06, Vol.79 (9), p.957-968

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Chronic kidney disease (CKD) is a major cause of morbidity and premature mortality and represents a significant global public health issue. Underlying this burden are the many complications of CKD, including mineral and bone disorders, anemia, and accelerated cardiovascular disease. Hyperphosphatemia and elevated levels of fibroblast growth factor...

Alternative Titles

Full title

Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6562046

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6562046

Other Identifiers

ISSN

0012-6667,1179-1950

E-ISSN

1179-1950

DOI

10.1007/s40265-019-01125-w

How to access this item